全文获取类型
收费全文 | 1492篇 |
免费 | 128篇 |
出版年
2022年 | 9篇 |
2021年 | 26篇 |
2020年 | 7篇 |
2019年 | 12篇 |
2018年 | 22篇 |
2017年 | 16篇 |
2016年 | 25篇 |
2015年 | 41篇 |
2014年 | 49篇 |
2013年 | 75篇 |
2012年 | 94篇 |
2011年 | 94篇 |
2010年 | 65篇 |
2009年 | 49篇 |
2008年 | 92篇 |
2007年 | 103篇 |
2006年 | 90篇 |
2005年 | 90篇 |
2004年 | 93篇 |
2003年 | 83篇 |
2002年 | 89篇 |
2001年 | 25篇 |
2000年 | 29篇 |
1999年 | 16篇 |
1998年 | 21篇 |
1997年 | 15篇 |
1996年 | 18篇 |
1995年 | 10篇 |
1994年 | 13篇 |
1993年 | 16篇 |
1992年 | 13篇 |
1991年 | 19篇 |
1990年 | 21篇 |
1989年 | 17篇 |
1988年 | 10篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 12篇 |
1984年 | 5篇 |
1983年 | 13篇 |
1982年 | 11篇 |
1981年 | 14篇 |
1979年 | 8篇 |
1978年 | 9篇 |
1977年 | 8篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1971年 | 7篇 |
1967年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有1620条查询结果,搜索用时 15 毫秒
111.
112.
Nishi M Mizushima A Nakagawara Ki Takeshima H 《Biochemical and biophysical research communications》2000,273(3):920-927
Junctophilin (JP) subtypes, namely JP-1, 2, and 3, have been currently identified in excitable cells and constitute a novel family of junctional membrane complex proteins. Our studies have suggested that JPs take part in the formation of junctional membrane complexes by spanning the membrane of the intracellular Ca(2+) store and interacting with the cell-surface membrane. In this report we describe the primary structures, genomic organization, and tissue distribution of human JP subtypes. By cloning and analyzing human genomic DNA segments, the protein-coding sequence interrupted with four introns was defined in each JP gene. The deduced human JP subtypes shared characteristic structural features with their rabbit and mouse counterparts. Genomic mapping demonstrated that JP genes do not cluster on the human genome. RNA blot hybridization indicated that tissue-specific expression patterns of JP genes in human are essentially the same as those in mouse; skeletal muscle contained both JP-1 and JP-2 mRNAs, the heart predominantly expressed JP-2 mRNA, and the brain specifically contained JP-3 mRNA. In the light of this, we propose intramolecular domains of JP subtypes based on the structural and functional characteristics. 相似文献
113.
A clear parallelism was demonstrated between the efficiency as substrate of the substituted oligopeptides corresponding to the carboxy-terminal (C-terminal) sequence of the precursor D1 protein (pD1) in the in vitro enzymatic assay and their competitive inhibitory capacity toward the proteolytic C-terminal processing of the full-length pD1 integrated in the intact photosystem II complex embedded in the thylakoid membrane of Scenedesmus obliquus LF-1 mutant, as shown e.g. by the influence of L343A, A345G and A345V substitutions and the effect of C-terminal fragments. This suggests that the basic mechanism for substrate recognition by the processing protease elucidated in the enzymatic analysis using synthetic oligopeptides is also effective in vivo, although it can sometimes be difficult to detect the consequence of amino acid substitution in the integrated systems. 相似文献
114.
Yumiko Nakagaito Motonobu Satoh Haruhiko Kuno Toshi Iwama Masao Takeuchi Akira Hakura Touho Yoshida 《In vitro cellular & developmental biology. Animal》1998,34(7):585-592
Summary We have established a multipotent clonal cell line, named MEB5, from embryonic mouse forebrains after the infection of a retrovirus
carrying E7 oncogene of human papillomavirus type 16. MEB5 cells proliferated in serum-free, epidermal growth factor (EGF)-supplemented
medium. They expressed markers for neural precursor cells (nestin, A2B5, and RC1) and did not express markers for neurons
(class III β-tubulin), astrocytes (glial fibrillary acidic protein), and oligodendrocytes (galactocerebroside). MEB5 cells
were stably maintained in an undifferentiated state with a diploid karyotype in the presence of EGF. When they were deprived
of EGF, about 50% of the cells died due apoptosis within 24 h. The remaining cells differentiated into neurons, astrocytes,
or oligodendrocytes within 2 wk. The newly developed cells with neuronal morphology were immunoreactive for γ-aminobutyric
acid and exhibited neuronal electrophysiological properties. When MEB5 cells were treated with leukemia inhibitory for 7 d,
they were induced to differentiate exclusively into astrocytes. These results inducate that MEB5 is a cell line with characteristics
of EGF-dependent, multipotent neural precursor cells. This cell line should provide a good model system to study the mechanisms
of survival, proliferation, and differentiation of the multipotent precursor cells in the central nervous system. 相似文献
115.
116.
Michiya Sugimori Yumiko Hayakawa Bruce M. Boman Jeremy Z. Fields Miharu Awaji Hiroko Kozano Ryoi Tamura Seiji Yamamoto Toru Ogata Mitsuhiko Yamada Shunro Endo Masanori Kurimoto Satoshi Kuroda 《PloS one》2015,10(8)
Background
Accumulating evidence indicates that cancer stem cells (CSCs) drive tumorigenesis. This suggests that CSCs should make ideal therapeutic targets. However, because CSC populations in tumors appear heterogeneous, it remains unclear how CSCs might be effectively targeted. To investigate the mechanisms by which CSC populations maintain heterogeneity during self-renewal, we established a glioma sphere (GS) forming model, to generate a population in which glioma stem cells (GSCs) become enriched. We hypothesized, based on the clonal evolution concept, that with each passage in culture, heterogeneous clonal sublines of GSs are generated that progressively show increased proliferative ability.Methodology/Principal Findings
To test this hypothesis, we determined whether, with each passage, glioma neurosphere culture generated from four different glioma cell lines become progressively proliferative (i.e., enriched in large spheres). Rather than monitoring self-renewal, we measured heterogeneity based on neurosphere clone sizes (#cells/clone). Log-log plots of distributions of clone sizes yielded a good fit (r>0.90) to a straight line (log(% total clones) = k*log(#cells/clone)) indicating that the system follows a power-law (y = xk) with a specific degree exponent (k = −1.42). Repeated passaging of the total GS population showed that the same power-law was maintained over six passages (CV = −1.01 to −1.17). Surprisingly, passage of either isolated small or large subclones generated fully heterogeneous populations that retained the original power-law-dependent heterogeneity. The anti-GSC agent Temozolomide, which is well known as a standard therapy for glioblastoma multiforme (GBM), suppressed the self-renewal of clones, but it never disrupted the power-law behavior of a GS population.Conclusions/Significance
Although the data above did not support the stated hypothesis, they did strongly suggest a novel mechanism that underlies CSC heterogeneity. They indicate that power-law growth governs the self-renewal of heterogeneous glioma stem cell populations. That the data always fit a power-law suggests that: (i) clone sizes follow continuous, non-random, and scale-free hierarchy; (ii) precise biologic rules that reflect self-organizing emergent behaviors govern the generation of neurospheres. That the power-law behavior and the original GS heterogeneity are maintained over multiple passages indicates that these rules are invariant. These self-organizing mechanisms very likely underlie tumor heterogeneity during tumor growth. Discovery of this power-law behavior provides a mechanism that could be targeted in the development of new, more effective, anti-cancer agents. 相似文献117.
118.
Takako Watanabe-Asano Akiko Kuma Noboru Mizushima 《Biochemical and biophysical research communications》2014
Protein synthesis inhibitors such as cycloheximide (CHX) are known to suppress protein degradation including autophagy. The fact that CHX inhibits autophagy has been generally interpreted to indicate that newly synthesized protein is indispensable for autophagy. However, CHX is also known to increase the intracellular level of amino acids and activate mTORC1 activity, a master negative regulator of autophagy. Accordingly, CHX can affect autophagic activity through inhibition of de novo protein synthesis and/or modulation of mTORC1 signaling. In this study, we investigated the effects of CHX on autophagy using specific autophagy markers. We found that CHX inhibited starvation-induced autophagy but not Torin1-induced autophagy. CHX also suppressed starvation-induced puncta formation of GFP-ULK1, an early-step marker of the autophagic process which is regulated by mTORC1. CHX activated mTORC1 even under autophagy-inducible starvation conditions. Finally, the inhibitory effect of CHX on starvation-induced autophagy was cancelled by the mTOR inhibitor Torin1. These results suggest that CHX inhibits starvation-induced autophagy through mTORC1 activation and also that autophagy does not require new protein synthesis at least in the acute phase of starvation. 相似文献
119.
120.